| Sales Revenue | Accumulated Sales Revenue | |||||
|---|---|---|---|---|---|---|
| MONTH | Year 2024 | Year 2023 | Increase (Decrease)(%) |
As of The End of This Month In Year 2024 |
The Corresponding Period In Year 2023 |
Increase (Decrease)(%) |
| JAN | 75,316 | 101,613 | (25.88) | 75,316 | 101,613 | (25.88) |
| FEB | 76,048 | 95,268 | (20.17) | 151,364 | 196,881 | (23.12) |
| MAR | 77,682 | 118,783 | (34.60) | 229,046 | 315,664 | (27.44) |
| APR | ||||||
| MAY | ||||||
| JUN | ||||||
| JUL | ||||||
| AUG | ||||||
| SEP | ||||||
| OCT | ||||||
| NOV | ||||||
| DEC | ||||||
UNIT : NT$ 1,000
NOTE：Starting 2013, MILDEX prepares financial statements in accordance with TIFRS (International Financial Reporting Standards as endorsed in R.O.C.),
MILDEX will report only consolidated financial figures from January 2013